NGNE
Price:
$21.16
Market Cap:
$327.75M
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Industry
Biotechnology
IPO Date
2014-03-07
Stock Exchange
NASDAQ
Ticker
NGNE
According to Neurogene Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Neurogene Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), NGNE's Dividend Yield was at its highest in in the September 2016 quarter at 0%. The Dividend Yield was at its lowest in in the September 2016 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Neurogene Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
The current Dividend Yield of Neurogene Inc. (NGNE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Neurogene Inc.’s Dividend Yield is less than Lineage Cell Therapeutics, Inc. (0%), less than Ocugen, Inc. (0%), less than Fulcrum Therapeutics, Inc. (0%), less than Autolus Therapeutics plc (0%), less than ADC Therapeutics S.A. (0%), less than Benitec Biopharma Inc. (0%), less than Solid Biosciences Inc. (0%), less than PureTech Health plc (0%), less than Quantum-Si incorporated (0%), less than Alumis Inc. Common Stock (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $400.26M | |
| 0% | $387.28M | |
| 0% | $474.02M | |
| 0% | $417.84M | |
| 0% | $409.60M | |
| 0% | $345.94M | |
| 0% | $461.22M | |
| 0% | $397.33M | |
| 0% | $287.46M | |
| 0% | $866.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurogene Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neurogene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Neurogene Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Neurogene Inc. (NGNE)?
What is the highest Dividend Yield for Neurogene Inc. (NGNE)?
What is the 3-year average Dividend Yield for Neurogene Inc. (NGNE)?
What is the 5-year average Dividend Yield for Neurogene Inc. (NGNE)?
How does the current Dividend Yield for Neurogene Inc. (NGNE) compare to its historical average?